Institut Pasteur clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   FIRST-IN-MOP · Optimal Dose of MOPEVAC-Las Vaccine Candidate…FIRST-IN-MOP · Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever

   Recruitment opened

   Also in this update: Start date changed from estimate of Sep 15, 2026 to Sep 28, 2026

   Institut Pasteur·Phase 1· NCT07833436· Registry history of NCT07833436 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.